Transplantation, HomologousHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousStem CellsBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningGraft SurvivalHematopoietic Stem Cell MobilizationTissue DonorsHematologic NeoplasmsHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorStem Cell TransplantationCord Blood Stem Cell TransplantationLeukapheresisBusulfanHistocompatibility TestingTreatment OutcomeKidney TransplantationLeukemiaGraft vs Tumor EffectRecurrenceWhole-Body IrradiationCombined Modality TherapyAntigens, CD34Blood Component RemovalEmbryonic Stem CellsRemission InductionImmunosuppressive AgentsRetrospective StudiesAdult Stem CellsTime FactorsGraft RejectionTransplantsMelphalanLeukemia, Myeloid, AcuteSurvival AnalysisCyclophosphamideSurvival RateDisease-Free SurvivalPluripotent Stem CellsTransplantation ChimeraHistocompatibilityCell DifferentiationMultiple MyelomaStem Cell NicheBlood CellsHeart TransplantationHematopoiesisAntineoplastic Combined Chemotherapy ProtocolsNeural Stem CellsFetal BloodInduced Pluripotent Stem CellsCyclosporineTransplantationMyeloablative AgonistsTransplantation, IsogeneicImmunosuppressionStem Cell FactorCytomegalovirus InfectionsBlood Cell CountMesenchymal Stem Cell TransplantationMultipotent Stem CellsLymphoma, Non-HodgkinTransplantation ImmunologyMesenchymal Stromal CellsBone Marrow CellsLung TransplantationInfectionAntineoplastic Agents, AlkylatingCell LineageVidarabineTacrolimusEtoposideCells, CulturedThiotepaCell SeparationFlow CytometryT-LymphocytesFollow-Up StudiesAnemia, AplasticColony-Forming Units AssayGraft vs Leukemia EffectHLA AntigensMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyHematologic DiseasesLymphocyte DepletionBlood DonorsBone MarrowTissue and Organ ProcurementAcute DiseaseImmunocompromised HostOpportunistic InfectionsAntigens, CDBone Marrow PurgingImmunophenotyping